USPTO serial 79278174
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,700
The Binding Site Group Limited
West Midlands, GB
The Binding Site Group Limited
West Midlands, GB
The Binding Site Group Limited
West Midlands, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenya Williams
Kenya Williams Thermo Fisher Scientific5781 Van Allen WayCarlsbad, CA 92008United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or research use; diagnostic and biological reagents for scientific or research use | ACTIVE | — |
| 005 | Reagents for medical or clinical use; chemical and biological preparations for use as calibrators in diagnostic assays for medical use; diluents for use in reconstituting and diluting other chemical and biological agents for medical or clinical use; chemical and biological preparations for use as control samples to validate calibration for medical use; diagnostic agents, preparations and substances for medical purposes; reagents for medical use; biological and biochemical preparations in the form of antibodies and antibody derivatives; all the foregoing for diagnostic use and all sold in kit forms; diagnostic and biological reagents for medical use | ACTIVE | — |
| 009 | scientific apparatus and instruments, namely, apparatus for using antibody coated magnetic beads and chemical and biological preparations for use as calibrators and controls for isolating and concentrating an analyte from a biological sample; scientific apparatus and instruments, for measuring the quantity of analytes to detect abnormalities in bodily fluids in the field of cancer, immunology, haematology, not for medical use; scientific and laboratory apparatus and instruments for liquid handling, namely, liquid analyzers, antibody coated magnetic beads and chemical and biological preparations for use as calibrators and controls for use in protein purification; scientific and laboratory apparatus and instruments, namely, plates and parts thereof having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use for plate spotting; diagnostic apparatus and instruments for detecting abnormalities in bodily fluids in the fields of cancer, immunology, haematology; apparatus for determining particle size and size distribution, namely, apparatus and instruments for mass spectrometry; Apparatus for measuring the concentration of particles, namely, apparatus and instruments for mass spectrometry; laboratory and scientific apparatus for affinity purification and measuring analytes; Apparatus for measuring the concentration of proteins, antibodies, antigens and other substances, namely, laboratory apparatus and computer systems for use in protein purification; sample analysing apparatus and equipment, namely, laboratory instrument for the detection and analysis of proteins and protein antigens for research and diagnostic use; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of scientific and laboratory apparatus and instruments and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of scientific apparatus and instruments for isolating and concentrating an analyte from a biological sample and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of scientific apparatus and instruments for measuring the quantity of analytes and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of scientific and laboratory apparatus and instruments for liquid handling and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of scientific and laboratory apparatus and instruments for plate spotting and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of diagnostic apparatus and instruments, other than for medical use; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of apparatus for determining particle size and size distribution and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of apparatus for measuring the concentration of particles and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of apparatus for affinity purification and measuring analytes and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of apparatus for measuring the concentration of proteins, antibodies, antigens and other substances and parts and fittings for all the aforesaid goods; computer operating software, encoded barcode machine readable data carriers and barcode readers for use in connection with or as parts of sample analysing apparatus and instruments [ * ; all of the aforesaid for medical, medical diagnostic and medical research purposes * ] * all of the aforesaid for medical, medical diagnostic and medical research purposes * | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, analyzers for medical diagnostic use for measurement of analytes in bodily fluid; Medical apparatus and instruments, namely, apparatus for blood analysis; Medical apparatus and instruments, namely, medical apparatus used in implementing diagnostic tests designed to detect abnormalities in blood, serum urine, CSF and plasma; medical diagnostic apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer, immunology, haematology; Medical devices for detecting cancer and immunological disorders; Medical apparatus for detecting cancer; medical diagnostic instruments for analysis of body fluids; Medical diagnostic apparatus for immunological testing and for laboratory testing on blood or bodily fluids or extracts from blood or body fluids, all being in kit form | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 24, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 21, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 18, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 18, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 21, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 22, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jan 16, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Dec 12, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 5, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 1, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jul 3, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 13, 2023 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 6, 2022 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Nov 3, 2022 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Nov 3, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jul 10, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 14, 2022 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Nov 30, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 11, 2021 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Apr 9, 2021 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Mar 30, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 28, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 3, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 9, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 9, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 18, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 18, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 2, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 2, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 2, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 2, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 2, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 28, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 12, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |